The role of calcium in essential arterial hypertension
Linari, F.; Bruno, M.; Marangella, M.
Minerva Urologica e Nefrologica 40(3): 201-205
1988
ISSN/ISBN: 0393-2249 PMID: 3070796 Document Number: 314808
Document emailed within 1 workday
Related Documents
Hergueta García de Guadiana, G.; Paumard Fraguas, A. 1989: Effects of a calcium antagonist, verapamil, on mild-moderate essential arterial hypertension Anales de Medicina Interna 6(1): 15-18Runikhina, N.K.; Tkacheva, O.N. 2008: Efficacy of long acting calcium antagonist felodipine in smoking women with essential arterial hypertension Kardiologiia 48(9): 50-52
Clémenty, J.; Dallocchio, M. 1979: Role of the heart in the genesis of essential arterial hypertension La Revue du Praticien 29(55): 4233
García-Ortiz, R.E. 1992: Diuretics and their current role in the treatment of essential arterial hypertension Revista Medica de Chile 120(6): 680-684
Pellegrino, L.; Prencipe, G. 1995: Ultrasonography of the carotid arteries in mild-to-moderate essential arterial hypertension and isolated systolic arterial hypertension Cardiologia 40(2): 109-116
Cloix, J.F.; Devynck, M.A.; Meyer, P. 1982: Plasma protein changes in essential arterial hypertension: a new genetic marker for arterial hypertension? Annales de Pediatrie 29(9): 655-656
De Gregorio, G.; De Gregorio, C. 1988: Treatment of arterial hypertension for cardio-cerebral protection: role of calcium antagonists La Clinica Terapeutica 127(5): 335-341
Postnov, I.V. 2001: The role of mitochondrial calcium overload and energy deficiency in pathogenesis of arterial hypertension Arkhiv Patologii 63(3): 3-10
Gassia, J.P.; Durand, D.; Suc, J.M. 1979: Essential arterial hypertension: initial therapeutic strategy or how to normalize arterial pressure La Revue du Praticien 29(57): 4395-4407
Duprez, D.A.; De Buyzere, M.L.; Verloove, H.H.; Kaufman, J.M.; Van Hoecke, M.J.; Clement, D.L. 1996: Influence of the arterial blood pressure and nonhemodynamic factors on regional arterial wall properties in moderate essential hypertension Journal of Human Hypertension 10(4): 251-256
De Ferrari, G.; Gaiter, A.; Ginevri, F.; Tizianello, A. 1979: Effects of pindolol on arterial pressure and plasma renin activity in essential hypertension and in hypertension during chronic renal insufficiency La Clinica Terapeutica 90(5): 461-468
Sokolova, L.A.; Bondarenko, B.B.; Evdokimova, T.A. 1992: Comparative evaluation of cardiovascular system reactivity in patients with borderline arterial hypertension and the early stages of essential hypertension Fiziologiia Cheloveka 18(1): 128-135
Andreeva, T.N. 1990: Foridone and other calcium antagonists in the treatment of essential hypertension Cor et Vasa 32(1): 45-55
Churin, K.V.; Ianushkene, T.S.; Kuznetsov, S.R. 1991: The membrane-bound calcium of the thrombocytes in essential hypertension Terapevticheskii Arkhiv 63(6): 96-98
Zapesochnaia, I.L.; Avtandilov, A.G. 2014: The influence of combined therapy with calcium antagonist and angiotensin-converting enzyme inhibitor on the circadian profile of arterial pressure in patients with arterial hypertension in the Far North Klinicheskaia Meditsina 92(10): 33-40
Caponnetto, S.; Allegro, A. 1987: Essential juvenile arterial hypertension Minerva Cardioangiologica 35(5): 261-266
Jazra, C. 1999: Arterial essential hypertension and associated pathologies Le Journal Medical Libanais. Lebanese Medical Journal 47(6): 343-348
Gunther, B. 1976: Pathology of essential arterial hypertension Revista Medica de Chile 104(1): 55-59
Le Quan Sang, K.H.; Montenay-Garestier, T.; Devynck, M.A. 1985: Platelet cytosolic free calcium concentration in essential hypertension Nouvelle Revue Francaise d'Hematologie 27(4): 279-283
García-Palmieri, M.R.; López de Jesús, F. 2003: Modern management of essential arterial hypertension Boletin de la Asociacion Medica de Puerto Rico 95(5): 9-14